Patent · US Active

Use of triplex structure DNA in transferring nucleotide sequences

US7981671B2 · kind B2 · utility

10Cited by
1References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 28, 2008
Grant dateJul 19, 2011
Priority date
Expiry dateSep 18, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2840/203
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention concerns a recombinant vector characterized in that it comprises a polynucleotide comprising a central initiation cis-active region (cPPT) and a termination cis-active region (CTS) of retroviral or retroviral-like origin, further comprising a predetermined nucleotide sequence (transgene or nucleotide sequence of interest) and retrotranscription regulating, expressing and packaging signals of retroviral or retroviral-like origin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.